首页 | 本学科首页   官方微博 | 高级检索  
     

地甘口服液支持环磷酰胺化疗的实验研究
引用本文:汪培国,邓静修,刘芳,陈如泉. 地甘口服液支持环磷酰胺化疗的实验研究[J]. 现代中西医结合杂志, 2002, 11(1): 17-19
作者姓名:汪培国  邓静修  刘芳  陈如泉
作者单位:1. 湖北省随州市中医医院,441300
2. 中国人民解放军第457医院血液科,湖北省,武汉市,430012
3. 湖北省中医学院附属医院,武汉市,430061
基金项目:湖北省自然科学基金项目 (97J0 80)
摘    要:目的 :观察地甘口服液提升白细胞并增强免疫力的作用。方法 :观察在不同时间段给予同剂量的地甘口服液 ,大剂量 CTX作用后小鼠外周血白细胞数量的变化 ,计量脾脏相关指标 ,与空白组和 CTX组对照。结果 :模后组与全程组小鼠白细胞数量、脾相关指标显著或非常显著地高于 CTX组 ( P<0 .0 5 ,P<0 .0 1) ,全程组统计学意义更为明显。结论 :地甘口服液有升高白细胞并恢复或加强免疫力的作用 ,化疗全程给药更有意义。

关 键 词:白细胞减少症  化学疗法  免疫  中医药疗法  地甘口服液

Experlmental study on Di-Gan-Oral-Liquor supporting chemotherapy of Cyclophosphamide
Wang Peiguo Suizhou Traditional Chinese Medicine Hospital,Suizhou ,Hubei,China Deng Jingxiu Hematology Department,PLA NO Hospital,Wuhan ,Hubei,China Liu Fang,Chen Ruquan The Affiliated Hospital of Hubei Traditional Chinese Medi. Experlmental study on Di-Gan-Oral-Liquor supporting chemotherapy of Cyclophosphamide[J]. Modern Journal of Integrated Chinese Traditional and Western Medicine, 2002, 11(1): 17-19
Authors:Wang Peiguo Suizhou Traditional Chinese Medicine Hospital  Suizhou   Hubei  China Deng Jingxiu Hematology Department  PLA NO Hospital  Wuhan   Hubei  China Liu Fang  Chen Ruquan The Affiliated Hospital of Hubei Traditional Chinese Medi
Affiliation:Wang Peiguo Suizhou Traditional Chinese Medicine Hospital,Suizhou 441300,Hubei,China Deng Jingxiu Hematology Department,PLA NO457 Hospital,Wuhan 430012,Hubei,China Liu Fang,Chen Ruquan The Affiliated Hospital of Hubei Traditional Chinese Medi
Abstract:Objective: It is to investigate the effects of Di-Gan-Oral-Liquor (DGOL) on raising quantities of WBC and improving immunity. Methods: The same dose of DGOL was offered at different periods. The changes of the quantities of WBC in peripheral blood were investigated, and the indices correlative with spleen were measured after the treatment of more dose of Cyclophosphamide (CY). Those materials were compared with space group and CTX group. Results: The quantities of WBC and the indices correlative with spleen in the group treated after modeled and the group treated all the experimental period were significantly superior than the CTX group ( P <0.05 or P <0.01). The group treated all the experimental period has obvious superiority. Conclusion: DGOL can raise the quantity of WBC and rebirth or enhance immunity, and can produce better effect when it is used within all the period of chemotherapy.
Keywords:lenkocytopenia chemotherapy immunity therapeutic method of TCM Di-Gan-Oral-Liquor
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号